eGFR Calculator
Kidney Function Test

What Is eGFR? A Complete Guide to Understanding Your Kidney Function

Your kidneys are among the most hardworking organs in your body. Every single day, they filter approximately 180 litres of blood, removing metabolic waste, excess minerals, and fluid, converting them into urine. The eGFR — estimated Glomerular Filtration Rate — is the single most important number that tells doctors and patients how well this filtration process is working.

The "glomerular" part refers to the glomeruli — the tiny, intricate filtering structures inside your kidneys. Each kidney contains roughly one million nephrons, each equipped with its own glomerulus. These microscopic filters collectively determine your kidney capacity. The GFR is the measurement of how much blood flows through all those glomeruli per minute, adjusted for a standard body surface area of 1.73 m².

The "estimated" prefix matters. Measuring true GFR directly requires complex procedures — injecting inulin or radioisotopes into the bloodstream and carefully measuring clearance rates over time. This is impractical for routine clinical use. Instead, eGFR is calculated from a simple blood test measuring serum creatinine, combined with your age and sex. The result is a highly reliable, widely validated estimate that forms the cornerstone of kidney disease diagnosis and management worldwide.

Why Is Serum Creatinine Used to Estimate Kidney Function?

Creatinine is a natural waste product that your muscles constantly produce through the breakdown of creatine phosphate during energy metabolism. Because healthy kidneys filter creatinine from the blood at a predictable, steady rate, its concentration in the bloodstream directly reflects how well your kidneys are performing.

When kidneys function normally, creatinine levels remain stable. As kidney function declines, creatinine accumulates in the blood — a clear biochemical signal. The mathematical relationship between serum creatinine concentration and kidney filtration capacity forms the basis of every eGFR equation, including the current gold-standard CKD-EPI 2021 formula.

The CKD-EPI 2021 Formula: Why It Matters and What Changed

For over a decade, kidney function was estimated using formulas that included race as a biological variable. This practice was rooted in studies showing that Black individuals often had higher average serum creatinine levels — which was attributed to greater average muscle mass. As a result, the older 2009 CKD-EPI equation applied a race multiplier that raised the eGFR estimate for Black patients.

In 2021, the National Kidney Foundation and the American Society of Nephrology jointly convened a Task Force to re-examine this practice. The conclusion was unambiguous: race should not be included in eGFR calculations. Race is a social construct, not a biological one, and using it in medical algorithms can mask true kidney disease severity in certain populations, leading to delayed diagnosis and treatment.

The CKD-EPI 2021 race-free equation was the result — equally accurate, scientifically rigorous, and far more equitable. Our calculator uses this updated formula exclusively, aligning with the current recommendations of NIDDK, NKF, ASN, and KDIGO.

CKD-EPI 2021 vs. Older MDRD Formula: Key Differences

Understanding the 5 Stages of Chronic Kidney Disease (CKD)

Chronic Kidney Disease (CKD) is not a sudden event — it unfolds gradually over months and years, often with no obvious symptoms until significant function has already been lost. The KDIGO (Kidney Disease: Improving Global Outcomes) framework classifies kidney disease into five stages based on eGFR, each with distinct clinical implications and management goals.

Stage G1 — Normal or High (eGFR ≥ 90)

An eGFR of 90 or above indicates that the kidneys are filtering blood effectively. However, Stage G1 CKD can still be diagnosed if there is evidence of kidney damage — such as protein in the urine (proteinuria), blood in the urine, or structural abnormalities visible on imaging — even when eGFR is normal. At this stage, the priority is identifying risk factors: controlling diabetes and high blood pressure, maintaining a healthy weight, and avoiding nephrotoxic medications.

Stage G2 — Mildly Decreased (eGFR 60–89)

A mild reduction in eGFR is extremely common, especially in people over 60. Age-related kidney decline naturally reduces eGFR by approximately 1 mL/min/year after age 40. An eGFR in this range, without additional markers of damage, may simply reflect normal aging rather than disease. Still, anyone with Stage G2 and risk factors for CKD should be monitored regularly, with annual blood tests at a minimum.

Stage G3a and G3b — Moderate Decrease (eGFR 30–59)

Stage 3 is where kidney disease begins to produce noticeable biochemical changes and sometimes mild symptoms. Waste products begin to accumulate in the blood, blood pressure control becomes more challenging, and the risk of cardiovascular complications rises. Anaemia may develop because declining kidneys produce less erythropoietin — the hormone that stimulates red blood cell production. Stage 3b (eGFR 30–44) carries a significantly higher risk of progression than Stage 3a. Referral to a nephrologist (kidney specialist) is recommended.

Stage G4 — Severe Decrease (eGFR 15–29)

At this stage, kidney function is severely compromised. Patients often experience noticeable fatigue, oedema (fluid retention in the legs and face), decreased urine output, and metabolic imbalances. Stage G4 requires close nephrology follow-up and marks the time to begin preparing for kidney replacement therapy — whether through dialysis (haemodialysis or peritoneal dialysis) or kidney transplantation. Nutritional modifications, typically a low-protein, low-potassium, low-phosphorus diet, become central to management.

Stage G5 — Kidney Failure (eGFR < 15)

Also called End-Stage Renal Disease (ESRD), Stage G5 represents near-total or complete kidney failure. The kidneys can no longer maintain the body's internal chemical balance, and life-sustaining kidney replacement therapy is required. Dialysis — filtering waste from the blood artificially — or a successful kidney transplant are the treatment options. Without intervention, this stage is life-threatening.

10 Factors That Affect Your eGFR Reading

Your eGFR is not a fixed number. Many physiological and lifestyle factors influence your serum creatinine level — and therefore your eGFR result. Understanding these helps you interpret fluctuations intelligently, rather than panicking over a single test result.

Symptoms of Declining Kidney Function: What to Watch For

One of the most dangerous aspects of kidney disease is its silence. In Stages G1 and G2, and often into G3, there are no noticeable symptoms. The kidneys have remarkable compensatory capacity — even when functioning at 50–60% of normal capacity, you may feel completely well. This is why regular testing is so important, particularly for high-risk individuals.

As kidney disease progresses to Stages G3b, G4, and G5, symptoms typically begin to emerge. These include persistent fatigue that does not improve with rest, swelling in the ankles, feet, and hands due to fluid retention, increased or decreased urination, foamy or bubbly urine (a sign of protein loss), difficulty concentrating, loss of appetite, nausea, itching skin (caused by waste product buildup), and shortness of breath. Importantly, these symptoms are non-specific — they can occur in many conditions. Only a blood test measuring serum creatinine and the resulting eGFR calculation can confirm kidney function status.

Who Should Monitor Their eGFR Regularly?

Regular eGFR monitoring is particularly important for individuals with established risk factors for kidney disease. The conditions and circumstances that significantly increase CKD risk include:

Type 1 or Type 2 Diabetes — Diabetic nephropathy is the single leading cause of kidney failure worldwide. Chronically elevated blood sugar damages the delicate filtration membranes of the glomeruli. All people with diabetes should have their eGFR and urine albumin-to-creatinine ratio (UACR) measured annually.

Hypertension (High Blood Pressure) — Uncontrolled high blood pressure is the second leading cause of kidney failure. It damages the arterioles supplying the glomeruli, progressively reducing filtration capacity. Anyone on antihypertensive medication or with readings consistently above 130/80 mmHg should monitor kidney function at least annually.

Age Over 60 — Natural age-related kidney decline means eGFR decreases with age even in perfectly healthy individuals. After 60, annual eGFR testing becomes part of standard preventive health care.

Family History of Kidney Disease — Genetic conditions such as polycystic kidney disease (PKD) run in families. If a first-degree relative has kidney disease, your personal risk is significantly elevated.

Obesity and Metabolic Syndrome — Obesity increases kidney filtration demands and promotes systemic inflammation, both of which accelerate kidney decline. People with a BMI over 30 should include kidney function testing in their annual health panel.

Recurrent Kidney Stones or Urinary Tract Infections — Structural kidney damage from stones or repeated infections can progressively impair function over time.

Long-term NSAID Use — Regular use of ibuprofen, naproxen, or other non-steroidal anti-inflammatory drugs reduces blood flow to the kidneys and accelerates damage, particularly in people who already have some degree of kidney impairment.

How to Protect and Improve Your Kidney Health

While you cannot reverse damage that has already occurred, there is strong evidence that lifestyle modifications can slow the progression of kidney disease, prevent further damage, and in early stages, even support modest improvements in eGFR. The following strategies are supported by clinical research and endorsed by nephrology organisations globally.

1. Control Blood Pressure Aggressively

Target blood pressure for people with CKD is generally below 130/80 mmHg, with some guidelines recommending even lower targets for those with significant proteinuria. ACE inhibitors (like ramipril) and ARBs (like losartan) are the preferred antihypertensive classes because they provide additional kidney-protective effects beyond lowering blood pressure, by reducing intraglomerular pressure and proteinuria.

2. Optimise Blood Sugar Control in Diabetes

Maintaining HbA1c (glycated haemoglobin) below 7% dramatically reduces the risk of diabetic nephropathy onset and slows its progression. Newer classes of diabetes medications — particularly SGLT2 inhibitors (such as empagliflozin and dapagliflozin) — have demonstrated direct kidney-protective effects independent of their glucose-lowering action, and are now recommended by KDIGO for people with CKD and diabetes.

3. Follow a Kidney-Friendly Diet

Dietary recommendations vary by CKD stage. In early stages (G1–G3a), reducing sodium intake to less than 2,300 mg per day supports blood pressure control. As kidney disease progresses, reducing dietary potassium (found in bananas, potatoes, and oranges) and phosphorus (found in dairy, cola drinks, and processed foods) becomes important to prevent dangerous blood level elevations. Working with a registered renal dietitian is strongly recommended for anyone in Stage G3b or higher.

4. Stay Well Hydrated — Without Overhydration

Adequate hydration keeps blood viscosity optimal, supports blood flow to the kidneys, and helps flush metabolic waste. Aim for pale yellow urine as a guide. However, people with advanced CKD or heart failure may need to restrict fluid intake on medical advice, so individualised guidance from your doctor is important.

5. Avoid or Minimise Nephrotoxic Medications

Several common over-the-counter and prescription medications can damage kidneys, particularly with regular use. NSAIDs (ibuprofen, naproxen, diclofenac) are the most commonly overused nephrotoxic drugs. Contrast dyes used in CT scans, certain antibiotics, and some herbal supplements (including aristolochic acid found in some traditional remedies) can also harm kidneys. Always disclose all medications and supplements to your healthcare provider.

6. Exercise Regularly

Regular moderate-intensity physical activity — such as walking, swimming, or cycling for 30 minutes, five days a week — improves blood pressure control, insulin sensitivity, cardiovascular health, and body weight, all of which benefit kidney function. Avoid excessive strenuous exercise immediately before creatinine testing, as intense exercise can temporarily elevate creatinine levels.

7. Stop Smoking

Smoking constricts blood vessels, raises blood pressure, and promotes endothelial dysfunction throughout the body — including the renal vasculature. Smokers have a significantly higher risk of developing CKD and experience faster progression once kidney disease is established. Smoking cessation is one of the most impactful modifiable risk factors for kidney health.

eGFR and the Urine Albumin-to-Creatinine Ratio (UACR): The Complete Picture

While eGFR is the primary measure of kidney function, it tells only half the story. The Urine Albumin-to-Creatinine Ratio (UACR) measures kidney damage — specifically, whether the filtering membranes are leaking protein that should normally be retained in the blood.

The combination of eGFR and UACR gives the most complete picture of kidney health. Someone with an eGFR of 80 (Stage G2 function) but significantly elevated UACR (Stage A3 albuminuria) has a much higher risk of CKD progression than someone with the same eGFR and no albuminuria. KDIGO's heat map of CKD risk uses both axes — eGFR category and albuminuria category — to determine overall prognosis and treatment intensity.

A UACR below 30 mg/g is considered normal (A1 category). Values of 30–300 mg/g indicate moderately increased albuminuria (A2), and above 300 mg/g represents severely increased albuminuria (A3), sometimes called macroalbuminuria or overt nephropathy.

How Often Should You Test Your Kidney Function?

The frequency of eGFR testing depends on your current kidney function stage and your risk factors. KDIGO provides specific guidance on monitoring frequency based on CKD category. People in Stage G1 with no risk factors may only need annual testing as part of a routine health check. Those in Stage G2 with diabetes or hypertension should test at least annually, and possibly every 6 months. Stage G3 patients typically need testing every 3–6 months, while Stages G4 and G5 require quarterly or more frequent testing, with close specialist involvement.

Beyond clinical testing, using an eGFR calculator after receiving your laboratory results empowers you to understand your own kidney health trajectory. Tracking your eGFR over time — building a personal record of values from successive blood tests — lets you and your healthcare team spot trends before they become crises.

Medications That Require eGFR-Based Dose Adjustment

One of the most clinically critical applications of eGFR is medication dosing. Many drugs are eliminated from the body primarily through kidney filtration. If kidney function is impaired and standard doses are used, these medications can accumulate to toxic levels. The following drug classes commonly require dose reduction or avoidance in CKD: metformin (diabetes), certain antibiotics (gentamicin, vancomycin, ciprofloxacin), direct oral anticoagulants (apixaban, rivaroxaban), NSAIDs, digoxin (heart), lithium (psychiatry), and contrast agents (imaging). Whenever a new medication is prescribed or reviewed, your doctor or pharmacist should consider your current eGFR.